The effects of cell density and device arrangement on the behavior of macroencapsulated β-cells

Cell Transplantation

Volumn 16, Issue 8, 2007, Pages 765-774

  La Flamme, Kristen E ^a   LaTempa, Thomas J ^b   Grimes, Craig A ^b   Desai, Tejal A ^c  

^a Boston University   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell density; Cell encapsulation; Diabetes; Immunoisolation; Cells

Indexed keywords

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL DENSITY; CELL ENCAPSULATION; CELL FUNCTION; CELL ISOLATION; CELL MEMBRANE; CELL VIABILITY; DEVICE; INSULIN RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 41349113579     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000007783465262     Document Type: Article

References (39)

1. Brenner, M. B.; Mest, H. J. A buffer temperature controlled perifusion system to study temperature dependence and kinetics of insulin secretion in MIN6 pseudoislets. J. Pharmacol. Toxicol. Methods 50(1):53-57; 2004.
2. Chao, S. H.; Peshwa, M. V.; Sutherland, D. E.; Hu, W. S. Entrapment of cultured pancreas islets in three-dimensional collagen matrices. Cell Transplant. 1(1):51-60; 1992.
3. Chick, W. L.; Like, A. A.; Lauris, V.; Galletti, P. M.; Richardson, P. D.; Panol, G.; Mix, T. W.; Colton, C. K. A hybird artificial pancreas. Trans. Am. Soc. Artif. Intern. Organs 21:8-15; 1975.
4. Colton, C. K. Implantable biohybrid artificial organs. Cell Transplant. 4(4):415-436; 1995.
5. Cozzi, E.; Bosio, E.; Seveso, M.; Vadori, M.; Ancona, E. Xenotransplantation - current status and future perspectives. Br. Med. Bull. 75-76:99-114; 2005.
6. Duvivier-Kali, V. F.; Omer, A.; Parent, R. J.; O'Neil, J. J.; Weir, G. C. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 50(8):1698-1705; 2001.
7. Efrat, S. Cell replacement therapy for type 1 diabetes. Trends Mol. Med. 8(7):334-339; 2002.
8. Efrat, S. Genetically engineered pancreatic beta-cell lines for cell therapy of diabetes. Ann. NY Acad. Sci. 875:286-293; 1999.
9. Emamaullee, J. A.; Shapiro, A. M. Factors influencing the loss of beta-cell mass in islet transplantation. Cell Transplant. 16(1):1-8; 2007.
10. Garcia-Ocana, A.; Vasavada, R. C.; Cebrian, A.; Reddy, V.; Takane, K. K.; Lopez-Talavera, J. C.; Stewart, A. F. Transgenic overexpression of hepatocyte growth factor in the beta-cell markedly improves islet function and islet transplant outcomes in mice. Diabetes 50(12):2752-2762; 2001.
11. Gong, D.; Yadavalli, V.; Paulose, M.; Pishko, M.; Grimes, C. A. Controlled molecular release using nanoporous alumina capsules. Biomed. Microdev. 5:75-80; 2003.
12. Hauge-Evans, A. C.; Squires, P. E.; Persaud, S. J.; Jones, P. M. Pancreatic beta-cell-to-beta-cell interactions are required for integrated responses to nutrient stimuli: Enhanced Ca2+ and insulin secretory responses of MIN6 pseudoislets. Diabetes 48(7):1402-1408; 1999.
13. Hayashi, H.; Inoue, K.; Aung, T.; Tun, T.; Yuanjun, G.; Wenjing, W.; Shinohara, S.; Kaji, H.; Doi, R.; Setoyama, H.; Kato, M.; Imamura, M.; Maetani, S.; Morikawa, N.; Iwata, H.; Ikada, Y.; Miyazaki, J. Application of a novel B cell line MIN6 to a mesh-reinforced polyvinyl alcohol hydrogel tube and three-layer agarose microcapsules: An in vitro study. Cell Transplant. 5(Suppl. 1):S65-69; 1996.
14. Ishihara, H.; Asano, T.; Tsukuda, K.; Katagiri, H.; Inukai, K.; Anai, M.; Kikuchi, M.; Yazaki, Y.; Miyazaki, J. I.; Oka, Y. Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets. Diabetologia 36(11);1139-1145; 1993.
15. Itoh, N.; Tomura, N.; Tsuji, T.; Hongo, M. Strengthened porous alumina membrane tube prepared by means of internal anodic oxidation. Microporous Mesoporous Mater. 20(4-6):333-337; 1998.
16. Kim, Y. T.; Hitchcock, R.; Broadhead, K. W.; Messina, D. J.; Tresco, P. A. A cell encapsulation device for studying soluble factor release from cells transplanted in the rat brain. J. Control Release 102(1):101-111; 2005.
17. Kobayashi, N. Cell therapy for diabetes mellitus. Cell Transplant. 15(10):849-854; 2006.
18. La Flamme, K. E.; Mor, G.; Gong, D.; La Tempa, T.; Fusaro, V. A.; Grimes, C. A.; Desai, T. A. Nanoporous alumina capsules for cellular macroencapsulation: Transport and biocompatibility. Diabetes Technol. Ther. 7(5):684-694; 2005.
19. La Flamme, K. E.; Popat, K. C.; Leoni, L.; Markiewicz, E.; La Tempa, T. J.; Roman, B. B.; Grimes, C. A.; Desai, T. A. Biocompatibility of nanoporous alumina membranes for immunoisolation. Biomaterials 28(16):2638-2645; 2007.
20. Lanza, R. P.; Ecker, D. M.; Kuhtreiber, W. M.; Marsh, J. P.; Ringeling, J.; Chick, W. L. Transplantation of islets using microencapsulation: Studies in diabetic rodents and dogs. J. Mol. Med. 77(1):206-210; 1999.
21. Leoni, L.; Desai, T. A. Micromachined biocapsules for cell-based sensing and delivery. Adv. Drug Deliv. Rev. 56(2):211-229; 2004.
22. Lim, F.; Sun, A. M. Microencapsulated islets as bioartificial endocrine pancreas. Science 210(4472):908-910; 1980.
23. Lopez, C. A.; Fleischman, A. J.; Roy, S.; Desai, T. A. Evaluation of silicon nanoporous membranes and ECM-based microenvironments on neurosecretory cells. Biomaterials 27(16):3075-3083; 2006.
24. Lu, H. F.; Targonsky, E. D.; Wheeler, M. B.; Cheng, Y. L. Thermally induced gelable polymer networks for living cell encapsulation. Biotechnol. Bioeng. 96(1):146-155; 2007.
25. Luther, M. J.; Davies, E.; Muller, D.; Harrison, M.; Bone, A. J.; Persaud, S. J.; Jones, P. M. Cell-to-cell contact influences proliferative marker expression and apoptosis in MIN6 cells grown in islet-like structures. Am. J. Physiol. Endocrinol. Metab. 288(3):E502-509; 2005.
26. Lysaght, M. J.; Aebischer, P. Encapsulated cells as therapy. Sci. Am. 280(4):76-82; 1999.
27. Miki, A.; Rivas-Carrillo, J. D.; Navarro-Alvarez, N.; Soto-Gutierrez, A.; Chen, Y.; Tanaka, K.; Narushima, M.; Tabata, Y.; Okitsu, T.; Noguchi, H.; Matsumoto, S.; Tanaka, N.; Kobayashi, N. Maintenance of neovascularization at the implantation site of an artificial device by bFGF and endothelial cell transplant. Cell Transplant. 15(10):893-901; 2006.
28. Miura, S.; Teramura, Y.; Iwata, H. Encapsulation of islets with ultra-thin polyion complex membrane through poly (ethylene glycol)-phospholipids anchored to cell membrane. Biomaterials 27(34):5828-5835; 2006.
29. Montanya, E. Islet- and stem-cell-based tissue engineering in diabetes. Curr. Opin. Biotechnol. 15(5):435-440; 2004.
30. O'Driscoll, L.; Gammell, P.; Clynes, M. Mechanisms associated with loss of glucose responsiveness in beta cells. Transplant. Proc. 36(4):1159-1162; 2004.
31. Ohgawara, H.; Miyazaki, J.; Nakagawa, S.; Sato, S.; Karibe, S.; Akaike, T. Xenoimplantation using a diffusion chamber with a B-cell line (MIN6) as a bioartificial endocrine pancreas (Bio-AEP). Cell Transplant. 5(Suppl. 1):S71-73; 1996.
32. Padera, R. F.; Colton, C. K. Time course of membrane microarchitecture- driven neovascularization. Biomaterials 17(3):277-284; 1996.
33. Papas, K. K.; Avgoustiniatos, E. S.; Tempelman, L. A.; Weir, G. C.; Colton, C. K.; Pisania, A.; Rappel, M. J.; Friberg, A. S.; Bauer, A. C.; Hering, B. J. High-density culture of human islets on top of silicone rubber membranes. Transplant. Proc. 37(8):3412-3414; 2005.
34. Roderigo-Milne, H.; Hauge-Evans, A. C.; Persaud, S. J.; Jones, P. M. Differential expression of insulin genes 1 and 2 in MIN6 cells and pseudoislets. Biochem. Biophys. Res. Commun. 296(3):589-595; 2002.
35. Suzuki, K.; Bonner-Weir, S.; Hollister-Lock, J.; Colton, C. K.; Weir, G. C. Number and volume of islets transplanted in immunobarrier devices. Cell Transplant. 7(1):47-52; 1998.
36. Suzuki, R.; Okada, N.; Miyamoto, H.; Yoshioka, T.; Sakamoto, K.; Oka, H.; Tsutsumi, Y.; Nakagawa, S.; Miyazaki, J.; Mayumi, T. Cyotomedical therapy for insulinopenic diabetes using microencapsulated pancreatic beta cell lines. Life Sci. 71(15):1717-1729; 2002.
37. Trivedi, N.; Keegan, M.; Steil, G. M.; Hollister-Lock, J.; Hasenkamp, W. M.; Colton, C. K.; Bonner-Weir, S.; Weir, G. C. Islets in alginate macrobeads reverse diabetes despite minimal acute insulin secretory responses. Transplantation 71(2):203-211; 2001.
38. Trivedi, N.; Suzuki, K.; Bonner-Weir, S.; Hollister-Lock, J.; Weir, G. C. Islet number in an immunobarrier device required to treat diabetes in mice. Transplant. Proc. 29(4):2142-2143; 1997.
39. Uludag, H.; De Vos, P.; Tresco, P. A. Technology of mammalian cell encapsulation. Adv. Drug Deliv. Rev. 42(1-2):29-64; 2000.